Kalbe Farma Tbk vs Saraswanti Anugerah Makmur Tbk. — how do they compare? Kalbe Farma Tbk trades at Rp720 (market cap 33T, 98.44M 24h volume), while Saraswanti Anugerah Makmur Tbk. trades at Rp276 (market cap 2.91T, 35K 24h volume). The key difference: Kalbe Farma Tbk is far larger — about 11.3× Saraswanti Anugerah Makmur Tbk.'s market cap, and Kalbe Farma Tbk is more actively traded (98.44M versus 35K). Which is the better fit depends on your goals.
| KLBF | SAMF | |
|---|---|---|
Market Cap | 33T | 2.91T |
Volume | 98.44M | 35K |
Lot | 984.38K | 350 |
Turnover | 70.64B | 9.75M |
Average Price | 717.58 | 278.53 |
Value | 70.64B | 9.75M |
Indicative Equilibrium Price | 720 | — |
Indicative Equilibrium Volume | 43.62K | — |
Trailing returns across standard periods
Latest headlines on both assets
PT Kalbe Farma Tbk (the Company) was established in the Republic of Indonesia, within the framework of the Domestic Capital Investment Law No. 6 Year 1968, as amended by Law No. 12 Year 1970, basedon Notarial Deed No. 3 of Raden Imam Soesetyo Prawirokoesoemo datedon September 10th, 1966. The Company, which started commercial operation in 1966.
Read more on KLBF →PT. Saraswanti Anugerah Makmur Tbk. (the Company) was established based on the Notarial Deed of Titiek Lintang Trenggonowati, S.H., No.15 dated June 18, 1998, notary in Surabaya.
Read more on SAMF →